Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DENSPM in Unresectable Hepatocellular Carcinoma
NCT00081900Phase 2Terminated
- Sponsor
- Sanofi
- Start
- Mar 2004
- Primary completion
- Jul 2007
- Countries
- 1
01
Overview
A Phase 2 trial of benspermine in hepatocellular carcinoma (HCC), sponsored by Sanofi. Started Mar 2004; status: terminated.
02
Drugs
benspermine
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00081900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00081900.